Catatonia in older adults: A systematic review
- PMID: 35317341
- PMCID: PMC8900590
- DOI: 10.5498/wjp.v12.i2.348
Catatonia in older adults: A systematic review
Abstract
Background: Catatonia is a complex psychomotor syndrome that often goes unrecognized and untreated, even though its classification has evolved in recent years. Prompt and correct identification of catatonia allows for highly effective treatment and prevention of possible complications. The underrecognition of catatonia in older patients is also frequent, and research in this population is scarce.
Aim: To conduct a systematic review of the literature on catatonia in older people to ascertain its clinical characteristics across settings.
Methods: Following the PRISMA guidelines, MEDLINE, EMBASE, and PsycINFO databases were searched from inception to December 2021, with a strategy aimed at identifying all articles published on catatonia in older adults. Titles and abstracts were scanned and selected independently by two authors. Papers investigating issues related to catatonia and/or catatonic symptoms in older people, with English abstracts available, were included. References of selected articles were revised to identify other relevant studies.
Results: In total, 1355 articles were retrieved. After removing duplicates, 879 remained. Of the 879 identified abstracts, 669 were excluded because they did not meet the inclusion criteria. A total of 210 articles underwent full text review, and 51 were eliminated for various reasons. Fourteen more articles were selected from the references. Overall, 173 articles were reviewed: 108 case reports, 35 case series, 11 prospective cohort studies, 6 case-control studies, 3 retrospective cohort studies and 10 reviews. We found several particular aspects of catatonia in this population. Catatonia in older patients is highly prevalent and tends to have a multifactorial etiology. Older patients, compared to younger patients, have a higher risk of developing catatonia with benzodiazepine (BZD) withdrawal, in bipolar disorder, and in the general hospital. Age, together with other risk factors, was significantly associated with the incidence of deep venous thrombosis, neuroleptic malignant syndrome poor outcome, other complications and mortality. Treatment with BZDs and electroconvulsive therapy is safe and effective. Prompt treatment of its cause is essential to ensure a good prognosis.
Conclusion: Catatonia in older patients is highly prevalent and tends to have a multifactorial etiology. The risk of developing catatonia in some settings and conditions, as well as of developing complications, is high in this population. Symptomatic treatment is safe and effective, and timely etiologic treatment is fundamental.
Keywords: Catatonia; Etiology; Older adults; Phenomenology; Prevalence; Treatment.
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
Conflict of interest statement
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Similar articles
-
Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144
-
Benzodiazepines for catatonia in people with schizophrenia or other serious mental illnesses.Cochrane Database Syst Rev. 2019 Aug 5;8(8):CD006570. doi: 10.1002/14651858.CD006570.pub3. Cochrane Database Syst Rev. 2019. PMID: 31425609 Free PMC article.
-
Systematic review of catatonia treatment.Neuropsychiatr Dis Treat. 2018 Jan 17;14:317-326. doi: 10.2147/NDT.S147897. eCollection 2018. Neuropsychiatr Dis Treat. 2018. PMID: 29398916 Free PMC article. Review.
-
The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426
-
[Acute catatonia: Questions, diagnosis and prognostics, and the place of atypical antipsychotics].Encephale. 2013 Jun;39(3):224-31. doi: 10.1016/j.encep.2012.06.032. Epub 2012 Oct 11. Encephale. 2013. PMID: 23095594 French.
Cited by
-
Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology.J Psychopharmacol. 2023 Apr;37(4):327-369. doi: 10.1177/02698811231158232. Epub 2023 Apr 11. J Psychopharmacol. 2023. PMID: 37039129 Free PMC article.
-
Acute Catatonia Following a Cerebellar Stroke: A Case Report.Cureus. 2024 Sep 18;16(9):e69645. doi: 10.7759/cureus.69645. eCollection 2024 Sep. Cureus. 2024. PMID: 39429282 Free PMC article.
-
Concurrent catatonia and COVID-19 infection in a demented patient: A case report.Psychiatry Res Case Rep. 2022 Jun;1(1):100011. doi: 10.1016/j.psycr.2022.100011. Epub 2022 Apr 30. Psychiatry Res Case Rep. 2022. PMID: 36704771 Free PMC article.
-
A Case of Acute Catatonia Precipitated by Psychosis Successfully Treated With Lorazepam: A Case Report.Cureus. 2023 Nov 29;15(11):e49648. doi: 10.7759/cureus.49648. eCollection 2023 Nov. Cureus. 2023. PMID: 38161877 Free PMC article.
-
Baclofen and catatonia: a case report.Pan Afr Med J. 2022 Dec 21;43:198. doi: 10.11604/pamj.2022.43.198.38403. eCollection 2022. Pan Afr Med J. 2022. PMID: 36942140 Free PMC article.
References
-
- Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand Suppl. 2013:1–47. - PubMed
-
- American Psychiatric Association (APA) Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association, 2013.
-
- Reed GM, First MB, Kogan CS, Hyman SE, Gureje O, Gaebel W, Maj M, Stein DJ, Maercker A, Tyrer P, Claudino A, Garralda E, Salvador-Carulla L, Ray R, Saunders JB, Dua T, Poznyak V, Medina-Mora ME, Pike KM, Ayuso-Mateos JL, Kanba S, Keeley JW, Khoury B, Krasnov VN, Kulygina M, Lovell AM, de Jesus Mari J, Maruta T, Matsumoto C, Rebello TJ, Roberts MC, Robles R, Sharan P, Zhao M, Jablensky A, Udomratn P, Rahimi-Movaghar A, Rydelius PA, Bährer-Kohler S, Watts AD, Saxena S. Innovations and changes in the ICD-11 classification of mental, behavioural and neurodevelopmental disorders. World Psychiatry. 2019;18:3–19. - PMC - PubMed
LinkOut - more resources
Full Text Sources